The use of nanometer-sized semiconductor crystals, known as quantum dots, allows us to directly observe individual biomolecular transactions through a fluorescence microscope. Here, we review the evolution of single quantum dot tracking over the past two decades, highlight key biophysical discoveries facilitated by quantum dots, briefly discuss biochemical and optical implementation strategies for a single quantum dot tracking experiment, and report recent accomplishments of our group at the interface of molecular neuroscience and nanoscience.
Introduction
Technological innovation in the field of fluorescence microscopy over the past two decades has elevated our ability to observe single molecules at work in living cells. A fluorescence microscope is now the backbone of modern molecular, cellular, and developmental biology labs, driving the discovery of molecular mechanisms that underlie fundamental biological processes. Single particle tracking (SPT) has emerged as a particularly powerful fluorescence microscopy technique, since it allows researchers to directly record how individual molecules traffic, interact, selfassemble, and undergo conformational changes at millisecond temporal and nanometer spatial resolution. One of the toughest early hurdles in SPT was the limited photon budget of a single molecule -an organic dye or a fluorescent protein only emit 10 5 to 10 6 photons before they enter a permanent nonemissive dark state, severely reducing the localization accuracy and trajectory duration [1] [2] [3] . Such rapid photobleaching of conventional fluorescent probes was overcome with the use of quantum dots (QDs), one of the first nanotechnologies integrated with biology [4, 5] . QDs are nanometer-sized semiconductor crystals that are characterized by relatively small size (2-10 nm) and size-tunable, narrow, Gaussian emission spectra. QDs feature broad absorption spectra, which readily enable multiplexed experiments with a single excitation source. Their high brightness is a product of high quantum yields, high molar extinction coefficients, and excellent photostability [1] [2] [3] [4] [5] . Although QDs were introduced to the field of biology in 1998, it took several years to optimize their colloidal stability in aqueous solutions and biocompatibility with live cell imaging. In 2003, QDs were for the first time implemented in a SPT experiment, wherein Dahan et al. imaged the rapid diffusion of QD-tagged endogenous glycine receptors in and out of FM4-64 dye-labeled synaptic boutons in the rat spinal cord cultures [6] . The ensuing QD-based discovery and characterization of the protein motion in living cells led to the following important discoveries: (i) the plasma membrane, in contrast to the ''fluid mosaic" model, is compartmentalized into dynamic, multi-tiered nanodomains stabilized and organized by cholesterol, actin cytoskeleton, and various scaffolding proteins [3, 7] ; (ii) the kinetic trapping by specialized nanodomains is an essential feature of the spatial organization and activity fine-tuning of transmembrane proteins [7, 8] ; (iii) transmembrane proteins undergo transient homo-and heterooligomerization in response to stimuli [7] ; and (iv) posttranslational modifications regulate neuronal protein synaptic recruitment via changes in lateral protein motion [8] . Moreover, several groups reported evidence of non-ergodic behavior of QD-tagged membrane proteins, breaking with the ergodic hypothesis, which postulates that tracking a single representative species over a long time period provides the same information about an ensemble of identical species as observing the ensemble itself [16] [17] [18] . Such time-and space-dependent variation in diffusivity of de-facto biochemically identical species in SPT studies is likely a manifestation of the conformational state flux, covalent protein modifications, ligand binding events, and transient interactions with the local microenvironment. In the same span of time, the following QD SPT developmental milestones were achieved -multiplexed SPT of up to 8 spectrally distinct QD species [9] , QD SPT in living rat brain slices [10, 11] , QD SPT in 3D by means of an astigmatic lens [12] , an engineered double helix point spread function [13] , or a multifocal plane setup [14] , and high-speed SPT at acquisition rates >1 kHz [15] (Table 1 ). In the subsequent sections of this article, we will provide a brief overview of important QD probe design considerations, describe a basic framework for optical QD SPT implementation to obtain highest quality data, and report key biological findings obtained using QD SPT in our group. Then, we will discuss the existing QD drawbacks, compare and contrast QD SPT with competing single-molecule imaging techniques, and offer possible solutions to the challenges that QD-based SPT is currently facing.
Designing a Quantum Dot Single Particle Tracking Experiment

QD probe generation and target specificity assessment
Arguably, specific recognition of the target biomolecule by any SPT probe is the most important property. Although fluorescent proteins offer perfect specificity due to the genetic fusion to the target protein, they are incompatible with endogenously expressed species, and it is often difficult to distinguish between membranelimited and intracellular diffusive events. On the other hand, nonspecific binding to the plasma membrane and the coverslip is a commonly encountered issue when using externally applied probes such as organic dyes and QDs [19] . In fact, the more hydrophobic organic dyes are notorious for such nonspecific binding, potentially introducing two types of artifacts into SPT experiments: (i) nonspecific dye adhesion to the substrate on which cells are cultured might result in a non-trivial increase in the immobile probe population and (ii) probes nonspecifically bound to the plasma membrane appear to exhibit pure Brownian motion and might diffuse at rates higher than the target biomolecule [19, 20] . In contrast, a commercially available QD architecture (Thermo Fisher Scientific) features a polyethylene glycol layer that effectively minimizes QD nonspecific binding to both the cell membrane and glass [21] , though it is still recommended that QD nonspecific binding is assessed on a case-by-case basis, with the necessary blocking reagents (serum, casein, nonfat dry milk) used to reduce the residual nonspecific binding.
Several approaches are available to impart the QD with target specificity [2, 3, 22] . The most popular strategy relies on the use of primary antibodies that recognize the extracellular epitope of the target protein. In a typical scenario, the extracellular domain of the transmembrane protein is first labeled with the primary antibody which is subsequently tagged with a QD conjugated to either a full secondary antibody or its antigen-binding fragment (Fab) (Fig. 1A) . The primary antibody bound to the target protein may also be labeled first with biotinylated secondary Fab fragments and then streptavidin-conjugated QDs. In another scenario, the primary antibody or its Fab fragment may be biotinylated and then used in conjunction with streptavidin-conjugated QDs. (Fig. 1B) If a primary antibody against the target protein extracellular domain is not readily available, a hybrid strategy may be utilized, wherein the target protein is genetically modified to contain an extracellular peptide insert at the termini or within one of the extracellular loops (Hemagglutinin, AP peptide, SNAP-tag, Halotag) which is subsequently recognized by the complementary probe conjugated to QDs [2, 3, 22] (Fig. 1D) . In a method reported by our group in 2002, QDs are targeted to the cell surface neurotransmitter transporters through the use of high-affinity, selective small-molecule ligands [23] (Fig. 1C) . Our current ligand-conjugated QD strategy utilizes a transporter-specific organic ligand composed of (i) a high-affinity parent drug (agonist or antagonist) that enables targeting of specific binding sites within the transporter structure and facilitates pseudo-irreversible binding, (ii) a short alkyl spacer which provides sufficient flexibility and a suitable hydrophobic interface for a successful drug-binding site interaction, (iii) a PEG polymer that aids in aqueous solubility and prevents nonspecific binding to the plasma membrane, and (iv) a biotin terminus that is captured by streptavidin-conjugated QDs upon the successful transporter-ligand binding event [24] [25] [26] [27] . To date, our lab has successfully demonstrated specific labeling of serotonin transporter (SERT), dopamine transporter (DAT), GABA c receptor, and D2 dopamine receptor (unpublished data) in either heterologous or endogenous expression systems [24] [25] [26] [27] [28] .
When evaluating QD target specificity, we recommend a transfected monolayer culture as the starting system because the accessibility of target proteins is significantly reduced in a complex three-dimensional tissue (e.g., brain slice). Also, the ability to properly wash out the unbound QDs is severely impacted in the intact tissue samples. The target specificity of QD-antibody conjugates can be directly evaluated by preincubating the primary antibody with the blocking peptide identical to the corresponding antigen sequence. In the case of ligand-conjugated QDs, the ligand-target interaction can be blocked by preincubating cells with a highaffinity antagonist (e. g., paroxetine for SERT). The use of nontransfected cells or small interfering RNA (siRNA) to silence the endogenous expression of the target molecule constitutes another important control, which allows one to determine the extent of nonspecific membrane binding. If the dynamic response of the target to an agonist or an antagonist is known, it is possible to indirectly test QD target specificity by modulating the behavior of the targeted molecule [29, 30, 11] . For instance, Varela et al. indirectly confirmed specific QD labeling of D1 dopamine receptors in cultured brain slices by observing the expected increase in D1 dopamine receptor diffusion rate after agonist administration [11] . One can also indirectly evaluate specific QD targeting by immobilizing target biomolecules via antibody crosslinking [31, 32] . When assessing QD target specificity in a complex sample, such as organotypic or acute brain slices, it might be necessary to implement a more quantitative approach. Biermann et al. introduced the ''enrichment factor' parameter, which is determined as the ratio of the number of QDs on transfected neurons in an organotypic brain slice to the number of QDs in the background [10] .
Optical implementation of a QD SPT experiment
Because a single QD is a robust and bright single photon emitter, optical implementation of a QD SPT experiment is fairly straightforward. Widefield optical microscopy has been the major workhorse in QD SPT due to its relative simplicity, lower cost, and readily attainable high frame rates (>10 Hz). If QD diffusion occurs predominantly at the plasma membrane-coverslip interface, total internal reflection (TIR) mode can be used to generate a standing wave or ''evanescent field" at the excitation point and thereby increase QD signal-to-noise ratio by eliminating out-of-focus intracellular autofluorescence. Another strategy to reduce background fluorescence is to utilize light-sheet illumination orthogonal to the objective and parallel to the imaging focal plane [33] . A high magnification (60x, or more) oil-immersion objective with a numerical aperture of !1.4 is typically used to yield images with the best signal-tonoise ratio (SNR) at the effective pixel size of $100 nm. The new generation of back-illuminated complementary metaloxidesemiconductor (CMOS) and electron-multiplying chargecoupled device (EMCCD) cameras with >90% quantum efficiency in the visible wavelength region and fast readout rates enable time-lapse single QD detection at integration times as low as several hundred microseconds with good SNR; however, a standard CCD, EMCCD, or CMOS camera is sufficient to achieve a benchmark frame rate of 30 Hz, allowing observation of such transient molecular events as receptor association with the membrane microdomains, stimulation-induced temporary arrest of receptor lateral diffusion (STALL), and receptor homo-or heterodimerization [3, 7] . Broad absorption spectra and enormous extinction coefficients of QDs mean that a single QD can be excited with virtually any source, including mercury or xenon arc lamps, light-emitting diodes, and lasers. Although QD signal improves at lower wavelengths (350-400 nm) due to the increasing extinction coefficient, a commonly used 488 nm excitation wavelength offers an effective compromise between QD signal quality and excitation-induced cellular cytotoxicity. It is also important to keep the excitation intensity at a minimum to reduce QD blinking and cellular photodamage; generally, an intensity of 0.5 kW/cm 2 is appropriate. Finally, QDs emitting in the red region of the visible spectrum (600-700 nm), where cell autofluorescence is low, are an optimal choice, as they readily facilitate parallel detection of GFP-or Alexa488-tagged biomolecules using the same excitation source in a multiplexed experiment [refer to Refs. [34, 35] for excellent detailed guides on SPT instrumentation]. Next, we will illustrate the utility of QD SPT by discussing our recent key findings from the interrogation of the dynamic behavior of plasma membrane monoamine neurotransmitter transporters, a class of neuronal proteins critical to synaptic transmission, plasticity, behavior, and disease.
Preparation of ligands for conjugation to QDs
The initial step of the ligand preparation is to select a suitable drug candidate. The drug molecule should possess high affinity for the protein target, with an optimal dissociation constant (K D ) below 10 À8 M, high selectivity of binding to the target over structurally related proteins, and a convenient reactive handle for further synthetic modification. Previously, we identified a high-affinity, homotryptaminebased SERT antagonist, 3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole, characterized by half-maximal inhibition (IC 50 ) of SERT-mediated serotonin uptake of 80 nM and featuring a basic nitrogen in the tetrahydropyridine ring amenable to conjugation. The synthetic route for generating biotinylated, PEGylated derivatives of 3-(1,2,3,6-tetra hydropyridin-4-yl)-1H-indole in Scheme 1 (Structures 1-9) [36] . Briefly, an alkyl chain spacer arm with 11 methylene units was attached to the basic nitrogen of the tetrahydropyridine ring by refluxing the parent drug with a phthalimide-protected alkyl bromide in acetonitrile in the presence of triethylamine. The phthalimide-protecting group was removed from the resulting products by treatment with hydrazine hydrate in ethanol to obtain the desired primary amine terminus. The intermediate was then coupled to biotin-PEG5000-Succinimidyl NHS ester to get the final crude product (IDT357). The crude product was purified by preparative HPLC and characterized by MALDI mass spectrometry. The biological activity of the biotinylated IDT357 was assessed using a two-step QD labeling protocol ( Fig. 2A) . The stably transfected SERT-expressing HEK293T cells grown in MatTek dishes were first labeled with 500 nM of the desired SERT ligand in the labeling buffer for 10 min, washed several times with ligand-free labeling buffer, and then incubated with a 1 nM solution of Qdot655 streptavidin conjugate in a 1% BSA (bovine serum albumin) imaging buffer for 5 min. The cells were then washed 3-5 times with QD-free imaging buffer to remove any unbound QDs and imaged immediately on a Zeiss widefiled epifluorescence microscope. A representative fluorescence image of hSERT-expressing cells labeled with biotinylated IDT357 and QD-streptavidin conjugates is shown in Fig. 2B . Successful labeling was apparent from a characteristic membrane-associated fluorescence, whereas the SERT-expressing cells preblocked with paroxetine, a high-affinity SERT inhibitor, displayed no such fluorescence. In addition to lower-magnification, whole-cell measurements, we also confirmed specific IDT357-mediated QD targeting of SERT by imaging YFP-SERT-transfected HEK293 cells using lower QD density and a 60x objective in the absence and presence of 10 mM paroxetine (Fig. 2C) . Paroxetine preblock eliminated virtually all of QD binding to SERT expressing cells, enabling the investigation of SERT diffusion dynamics reported in Section 1.6. The presynaptic, antidepressant-sensitive SERT has emerged as a major determinant of an individual's risk of neuropsychiatric illness [37] . Although biochemical studies have shown that regulation of SERT activity is intimately linked to its residence in specialized, cholesterol-and GM1 ganglioside-rich membrane microdomains, investigation of the spatiotemporal membrane organization of single SERT proteins has been hampered by the poor resolution of available methods [25] . To this end in 2012, our group reported the first use of the ligand-conjugated QD labeling strategy to capture the plasma membrane dynamics of single SERT proteins endogenously expressed in immortalized serotonergic rat neurons RN46A [25] . The first measurement of single SERT diffusion provided direct proof that SERT exists as two distinct pools in the membrane of untreated RN46A cells, with the dominant fraction ($90%) displaying highly restricted diffusion and the remaining pool diffusing at a significantly faster rate in an unconstrained manner. Parallel imaging of Alexa488-tagged cholera toxin B, a marker of cholesterol-and GM1 ganglioside-rich membrane microdomains, demonstrated a high degree of SERT-QD colocalization with cholera toxin B membrane patches. Partial cholesterol depletion of RN46A cells with methyl-bcyclodextrin, a cyclic glucose oligomer capable of sequestering membrane cholesterol, resulted in a dramatic increase in the overall diffusion rate and a complete loss of the restricted SERT pool, indicating that the restricted diffusion of SERT under basal conditions stems from its localization to the membrane microdomains (Fig. 3) . Lateral acceleration of SERT proteins after cholesterol depletion was accompanied by a pronounced dispersal of cholera toxin B membrane patches. By applying the 5-second radial displacement analysis to single SERT trajectories, we determined that the overwhelming majority of SERT proteins under basal conditions reside in the putative microdomains approximately 500 nm in diameter. Furthermore, the restricted SERT pool appeared to be under the constitutive control of p38 mitogen-activated protein kinase (p38 MAPK) pathway. The mammalian p38 MAPK family is a group of intracellular kinase enzymes mediating cellular response to various stressors (UV radiation, inflammatory cytokines, heat shock, osmotic shock) and promoting an increase in SERT transport activity in part through phosphorylation, a biochemical event that involves the addition of a phosphate group to the serine, threonine and tyrosine side chains [38] . We observed that activation of the p38 MAPK pathway induced accelerated SERT lateral movement, with the majority of SERT proteins remaining constrained in the putative membrane microdomains. The effects of actin cytoskeleton disruption on SERT mobility were analogous to those observed during p38 MAPK activation, prompting us to hypothesize that catalytic SERT activation proceeds via partial dissociation of SERT proteins from the actin cytoskeleton within the cholesterol-and GM1 ganglioside-rich membrane microdomains. Our findings demonstrated that QD SPT is capable of illuminating the molecular details of pharmacological manipulation and catalytic activation of single proteins in living cells occurring over milliseconds to seconds at the nanoscale.
QDs reveal altered diffusion dynamics of the ADHD-associated Arg615Cys dopamine transporter coding variant
In another application of the ligand-conjugated QD labeling approach, we established the dynamic imaging of membrane dopamine transporter (DAT) proteins at the single-molecule level for the first time [27] . DAT is the primary mechanism of shaping synaptic dopaminergic transmission, as it actively clears extracellular dopamine into the presynaptic terminals [39] . Notably, DAT is the primary target for drugs of abuse such as cocaine and amphetamine as well as therapeutic drugs such as methylphenidate (Ritalin) [39] [40] [41] [42] [43] . Naturally occurring DAT coding variation reported in subjects diagnosed with the attention deficit/hyperactivity disorder (ADHD), autism spectrum disorder (ASD), and infantile Parkinsonism causes anomalous dopamine efflux, complete loss of function, or trafficking dysregulation [40] [41] [42] [43] . We sought to apply the ligand-conjugated QD SPT framework to investigate the membrane dynamics of the ADHD-derived R615C DAT variant. This DAT mutant features an argninine-to-cysteine substitution at position 615 in the intracellular C-terminus and had been previously shown in ensemble experiments to redistribute away from the GM1 ganglioside-rich membrane microdomains [40] . QD SPT analysis of the diffusion dynamics of the wildtype and R615C DAT proteins in a stably transfected HEK293 cell line revealed that the ADHD-derived DAT variant exhibited accelerated membrane movement in contrast to the wildtype DAT protein (Fig. 4) . The accelerated basal membrane dynamics were accompanied by the failure of the R615C DAT proteins to mobilize after lipid raft disruption achieved through partial cholesterol depletion, whereas the diffusion rate of the wildtype DAT after partial cholesterol depletion was comparable to that of the R615C variant under basal conditions. Additionally, the administration of amphetamine, a potent multifaceted DAT modulator, failed to mobilize the R615C DAT proteins as opposed to the wildtype DAT, consistent with the previously observed insensitivity of the R615C variant to amphetamine-induced internalization. Together, these QD SPT findings point to a membrane microdomain mislocalization of the ADHD-associated DAT mutant that is likely driven by the transporter's constitutively hyperphosphorylated status.
QDs reveal altered diffusion dynamics of the autism-associated Gly56Ala SERT coding variant
Multiple naturally-occurring, brain disorder-associated coding variants have also been identified for the SERT protein, fundamentally altering transporter function and regulation [44] . One such gain-of-function variant, Gly56Ala (G56A) SERT, has been associated with autism spectrum disorder (ASD), a highly prevalent brain disorder characterized by impaired social communication and abnormal sensory processing [44, 45] . In fact, the G56A allele is carried by approximately 1 in 200 Caucasian subjects, representing more than a million Americans. G56A SERT displays an elevated constitutive phosphorylation rate and the complete loss of sensitivity to p38 MAPK-mediated phosphorylation, thus enabling the investigation of the direct link between the transporter phosphorylation status and its lateral mobility [45] .
To capture membrane dynamics of G56A and WT SERT in stably transfected Chinese hamster ovary (CHO) cells, a biotinylated, SERT-selective ligand IDT357 was used in conjunction with streptavidin-conjugated QDs as described in Section 1.2 and SI. Membrane movement of QD-tagged SERTs was recorded for 1 min at the acquisition rate of 10 Hz, and the motion parameters (Fig. 5A and B) . To visualize the extent of lateral movement of QD-tagged SERT proteins from the starting position over a 5 s recording interval (5-sec dr), we plotted radial displacement of each variant in Fig. 5 . The G56A variant traveled slightly but significantly farther than wild type SERT (one-way ANOVA, p < 0.01) (Fig. 5C and D) . We hypothesize that the mutation to alanine disrupts G56A SERT membrane microdomain localization and key associations with the SERT membrane interactome, resulting in a dysregulated dynamic phenotype. Interestingly, in addition to the abnormal diffusion dynamics exhibited by brain disorder-associated DAT and SERT variants in our studies, Jezequel et al. recently determined that circulating autoantibodies derived from the blood serum of psychotic patients diagnosed with schizophrenia directly destabilize surface dynamics and nanoscale organization of the synaptic glutamate NMDA receptors [46] . We believe that spatiotemporal membrane disorganization of neuronal proteins is emerging as a central molecular pathological theme in brain disorder research (Table 2) .
QD-based approach to survey 3D distribution and dynamics of endocytosed transporters
Decades of research efforts aimed at unraveling the intricacies of neurotransmitter transporter trafficking support the notion that membrane pool of transporters is in constant flux, and proper transporter turnover represents an important modulatory mechanism of synaptic plasticity. Membrane transporters undergo marked constitutive and regulated redistribution away from the plasma membrane driven in part by amino-/carboxy-terminal linear motifs, conformational shifts, and covalent modifications [47] [48] [49] . Although transporter turnover is an essential component of neurotransmission, the intracellular dynamics and subsequent fate of individual transporters remain poorly understood. Our ligand-conjugated QD approach is uniquely suited to interrogate the intracellular dynamics of transporters in living cells because (i) pseudoirreversible ligand binding ensures that the transporter-QD complex remains intact post-endocytosis and (ii) bright and stable QD signal enables prolonged observation of single cargo trafficking [26, 27] . A proof-of-concept implementation of our QD labeling approach together with spinning-disk confocal microscopy to investigate DAT endocytic trafficking is shown in Fig. 6A . Notably, the spinning-disk microscope is equipped with a z-axis piezo nanopositioning stage, which enabled capture of transient endocytic events and robust single cargo localization analysis. At z-speeds of 10 300-nm steps per second, 3D image stacks were acquired to detect QD-DAT complexes relative to the plasma membrane of transiently transfected HEK293 cells, conveniently labeled with a CellMask TM lipophilic membrane stain (Fig. 6B ) (refer to SI for experimental details). Binarizing the acquired z-stacks and performing 2-channel colocalization analysis allows us to discriminate intracellular QDs from those localized to the plasma membrane ( Fig. 6C-E) . By incorporating an additional fluorescent marker of early recycling endosomes or late degradative compartments, our approach could be a valuable tool for quantitative determination of DAT intracellular fate at the single-cargo 
Table 2
Destabilization of surface diffusion dynamics of membrane proteins in human disorders.
Genetic Cause Molecular Phenotype Disorder Reference
Mutated stargazin, a protein responsible for synaptic accumulation of a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors increased AMPAR lateral mobility absence epilepsy, cerebellar ataxia [59] Deletion of N-cofilin, a key regulator of synaptic actin turnover and dendritic spine shape/size increased extrasynaptic AMPAR mobility associative learning impairment [60] Delta-F508 mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel delta-F508 CFTR diffusion more rapid than wildtype CFTR cystic fibrosis [61] Copy number variation of the cytoplasmic FMRP-interacting protein 1 (CYFIP1), critical for maintenance of dendritic spine complexity and morphology increased AMPAR mobility in synaptic clusters of CYFIP1-deficient neurons schizophrenia, autism spectrum disorder [62] Exon1 mutations in huntingtin, resulting in the polyglutamine expansion increased AMPAR mobility Huntington's disease [63] C-terminus R615C mutation in dopamine transporter (DAT) DAT-R615C diffusion more rapid than wildtype DAT attention deficit/ hyperactivity disorder [27] N-terminus G56A mutation in serotonin transporter (SERT) SERT-G56A diffusion more rapid than wildtype SERT autism spectrum disorder
Here in Section 3.3 Serum autoantibodies against N-methyl-D-aspartate glutamate receptors (NMDAR) * increased NMDAR mobility and synaptic exchange rate schizophrenia, psychosis [46] Asterisk denotes a non-genetic underlying cause of the disorder.
level in 3D. Furthermore, time-lapse imaging of a single-plane cross-section of a cell with internalized QD-DAT complexes permits quantitation of single cargo movement at millisecond temporal resolution with exceptional SNR (Fig. 7) .
Challenges and prospects
Size
Commercially available biofunctionalized QDs are comprised of an inorganic core/shell, an amphiphilic polymer shell, a PEG layer, and multiple copies of either a divalent antibody or a tetravalent streptavidin on the surface. Together, these components contribute to the complex QD architecture far exceeding the hydrodynamic diameter of 20 nm and the molecular mass of 1,000,000 Da [2] . In fact, these dimensions are several orders of magnitude larger than the size of a typical membrane protein target (5-10 nm and 50-100 kDa). Therefore, it is a valid concern that a bulky and polyvalent QD probe might restrict access to the crowded cellular compartments (e.g., synaptic cleft) and influence the intrinsic diffusion pattern of the targeted biomolecule. To date, several groups have systematically examined this issue, and the results have been conflicting. Domanov et al. demonstrated that the viscous drag on a QD bound to a protein is dominated by the mobility of the target anchored in the membrane [64] . Pierobon et al. explored the QD drag effects when tagged to a molecular motor myosin V and determined that the size of the probe does not affect the motion and processivity of myosin V [65] . Groc et al. found that the diffusion rate of extrasynaptic glutamate receptors tagged with QD-antibody conjugates did not differ significantly from that of receptors tagged with either dye-conjugated antibodies or small peptides [66] . However, Groc et al. also reported that the fraction of synaptic QD-tagged glutamate receptors was significantly reduced compared to dye-tagged receptors [66] . This finding was recently corroborated by Lee et al. that observed nearly complete elimination of the mobile pool of extrasynaptic glutamate receptors when replacing commercial QDs with custom-made compact QDs or Atto dyes [67] . Nechyporuk-Zloy et al. reported that QDs slowed down the membrane diffusion and changed the type of motion of potassium channels when compared directly to Alexa488 dye [68] . In addition, Howarth et al. discovered that commercial streptavidin-conjugated QDs limited the access of glutamate receptors to the synaptic cleft and triggered surface clustering and internalization of the surface ephrin receptor [69] . Recently, Abraham et al. demonstrated that Fab-conjugated QDs hinder B cell receptor diffusion on multiple glass coating substrates when compared directly to Cy3-Fab conjugates [70] . It appears that the large QD size might significantly perturb the intrinsic diffusivity of the targeted biomolecule, and it is therefore imperative that one performs an orthogonal tracking experiment to validate the diffusion dynamics observed via QD SPT. In parallel, synthetic efforts have been under way to reduce QD size; the primary focus is on replacing the bulky amphiphilic polymer shell with low molecular weight polymers [71] or displacing the native hydrophobic ligands with mono-and bidentate PEGylated alkanethiols [67, 72] . Another alternative is the use of imidazolebased block copolymers [73] . Recently, Farlow et al. utilized the affinity of phosphorothioate oligonucleotides for the semiconductor surface to prepare monovalent DNA-functionalized QDs [74] . However, the generation of compact QDs typically requires stripping of native organic ligands which renders compact QDs prone to aggregation and negatively affects optical properties [71, 73] . Also, smaller size as a rule results in increased nonspecific binding. As such, the research efforts to date have yet to result in a commercially viable class of compact QDs.
Blinking
Even under constant illumination, almost all colloidal nanocrystals exhibit a signature stochastic intermittency in their photoluminescence spectra, a phenomenon first observed by Nirmal et al. [75] Currently, it is widely accepted that QD blinking appears to originate from the illumination-induced trapping of a charge carrier either within or at the surface of the QD (''on" ? ''off"), and subsequent nonradiative recombination neutralizes the charged QD and returns it to the emissive state (''off" ? "on") [76] . In the context of SPT experiments, QD blinking serves as a useful criterion to ensure the observation of single nanocrystal species. On the other hand, QD blinking does not allow the recording of trajectories as a continuum; this disadvantage necessitates the use of advanced algorithms to minimize false correspondence of trajectory segments. Systematic study of the ''on"/"off" emissive state switching revealed a pronounced dependency on the excitation intensity, excitation wavelength, shell composition, and shell thickness [76] [77] [78] . Our group developed a correlation technique that utilizes widefield optical microscopy and atomic number contrast scanning transmission electron microscopy (Z-STEM) to directly interrogate the contribution of the internal and surface QD defects to the rate of nonradiative recombination [77, 78] . Synthetic control of QD blinking rate has been pursued by multiple groups; blinking suppression can be achieved by passivating QD cores with a thick multilayer shell and/or interfacial alloying that results in a smooth radial QD composition change and consequently in a soft confinement potential [77] . These new blinking-suppressed materials represent an attractive option for SPT experiments, as they would eliminate the need to account for gaps during trajectory reconstruction. In some cases, the stochastic nature of blinking is desirable and facilitates superresolution imaging of diffraction-limited QD spots separated by nanometer distances [79] . Furthermore, we anticipate that achieving precise synthetic control over the QD blinking rate will potentially enable single-channel, super-resolution multiplexing of biomolecules tagged with fast-blinking and slow-blinking QDs using standard instrumentation.
Competing technologies
We would be remiss not to acknowledge recent advances in the realm of organic dye-and fluorescent protein-based superresolution imaging. In fact, the predominance of QDs in the SPT studies in the monolayer culture has been considerably diminished with the advent of brighter, more photostable dyes [80] and the proliferation of the alternative tracking methods based on the stochastic single-molecule localizations [7] . Although QD photostability underlies the ability to monitor prolonged QD diffusion, it is now possible to obtain high-resolution tracks of dye-tagged biomolecules at millisecond time resolution, even for as long as 7 min in reduced oxygen environment [81] . Nevertheless, we are confident that QDs will remain the probe of first choice in multiplexing experiments and in applications that require very bright and photostable probes, such as 3D SPT or tracking in ex vivo tissue slices or in vivo.
Conclusions
Since its advent in 1980s, SPT provided a powerful experimental avenue to directly examine important biological events in living cells at the length and time scales elusive to the ensemble biochemical techniques. QD technology has been an integral element of the groundbreaking success of SPT, owing to the superior photophysical performance of single QD emitters. Since the seminal report of Dahan et al. in 2003, QD SPT revolutionized our understanding of the dynamic plasma membrane architecture, shed light on the composition and assembly of synaptic supramolecular protein complexes, unraveled the molecular mechanisms of viral entry into living cells, and mapped out the initial signaling events involved in the innate immune response. In the same period of time, our lab developed the ligand-conjugated QD labeling strategy to target transmembrane neurotransmitter transporters and applied the QD SPT framework to decipher the dynamic membrane organization of the transporters. Importantly, our QD SPT studies have identified a direct functional impact of the brain disorderassociated coding variation on transporter membrane diffusion dynamics, supporting pathogenic relevance of dysregulated surface trafficking of proteins involved in neurotransmission. We envision that the enormous QD photon budget will permit examining molecular interactions at the micro-to -millisecond timescale in native 3D environment ex vivo and ultimately in vivo.
